USING HEPTAPEPTIDE FOR TREATING PARKINSON'S DISEASE AND METHOD OF TREATING SUCH DISEASE

摘要

FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine, and concerns using heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selinc). ^ EFFECT: intranasal application of the preparation in the concentration of 0,15 % in dose four to six drops in each nostril every 4-5 hours for 2-3 weeks allows higher clinical effectiveness in Parkinson's disease ensured by correction of neuropsycological disorders. ^ 3 cl, 4 ex